Genipin inhibits proliferation of gastric cancer cells by inducing ferroptosis: an integrated study of network pharmacology and bioinformatics study
- 4 January 2024
- journal article
- research article
- Published by Springer Nature in Medical Oncology
- Vol. 41 (2) , 1-12
Abstract
Ferroptosis has been demonstrated to suppress cancer development and is targeted for cancer therapy. Genipin, an iridoid constituent in Gardeniae Fructus, has been reported to exert anti-cancer abilities. However, whether genipin could induce ferroptosis remains unclear. The purpose of this study is to explore the anti-gastric cancer (GC) effects of genipin by inducing ferroptosis and to identify the potential targets. CCK-8 and colony formation assays were performed to evaluate the anti-GC effects of genipin. Flowcytometry and western blot were used to indicate ferroptosis-inducing ability of genipin. The potential targets of genipin were analyzed by network pharmacology, screened using UALCAN and KM-plotter database and evaluated by molecular docking. The results showed that genipin inhibited cell viability and proliferation of GC cells. Genipin treatment decreased levels of GPX4 and SLC7A11, induced accumulation of lipid peroxidation intracellularly and led to ferroptosis in GC cells. Network pharmacology analysis identified that lipid- and ROS-related pathways involved in ferroptosis ranked high among genipin-GC common targets. Data from UALCAN and KM-plotter database demonstrated that expression levels of ferroptosis-related targets, including AURKA, BCAT2, DHODH, and GPI, increased in GC tissues and the higher levels of the above four targets were related to tumor stage, tumor grade, and poor prognosis. Among these four targets, AURKA, BCAT2, and DHODH were confirmed by molecular docking with binding energies less than − 5. Taken together, our study demonstrates that genipin could exert anti-GC ability by inducing ferroptosis and provides evidence for the potential application of genipin in GC treatment.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020MH298)
This publication has 38 references indexed in Scilit:
- Genipin Enhances the Therapeutic Effects of Oxaliplatin by Upregulating BIM in Colorectal CancerMolecular Cancer Therapeutics, 2019
- Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2Phytotherapy Research, 2018
- Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancerCancer Management and Research, 2018
- Genipin induces cell death via intrinsic apoptosis pathways in human glioblastoma cellsJournal of Cellular Biochemistry, 2018
- Medicinal supplement genipin induces p53 and Bax‑dependent apoptosis in colon cancer cellsOncology Letters, 2018
- Disrupting the ‘Warburg effect’ re-routes cancer cells to OXPHOS offering a vulnerability point via ‘ferroptosis’-induced cell deathAdvances in Biological Regulation, 2018
- Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signalingOncology Letters, 2017
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- Effects of Mitochondrial Uncoupling Protein 2 Inhibition by Genipin in Human Cumulus CellsBioMed Research International, 2015
- P38 MAP Kinase Mediates Apoptosis After Genipin Treatment in Non^|^ndash;Small-Cell Lung Cancer H1299 Cells via a Mitochondrial Apoptotic CascadeJournal of Pharmacological Sciences, 2013